Search

Bing Zhu Phones & Addresses

  • 8262 Magnolia Village Dr, Mobile, AL 36695 (251) 639-3122
  • 1663 Hillcrest Rd, Mobile, AL 36695 (251) 639-3122
  • 207 Hillcrest Rd, Mobile, AL 36608
  • Huntsville, AL

Resumes

Resumes

Bing Zhu Photo 1

Assistant Professor Of Oncologic Sciences

View page
Location:
Mobile, AL
Industry:
Higher Education
Work:
Drug Discovery Research Center Mitchell Cancer Institute University of South Alabama
Assistant Professor of Oncologic Sciences

University of South Alabama College of Medicine Department of Pharmacology Aug 2008 - Oct 2011
Assistant Professor

University of South Alabama College of Medicine Department of Pharmacology Jan 2005 - Jul 2008
Instructor
Bing Zhu Photo 2

Assisstant Professor

View page
Location:
Mobile, AL
Industry:
Research
Work:
University of South Alabama
Assisstant Professor
Bing Zhu Photo 3

Bing Zhu

View page
Skills:
Microsoft Office
Microsoft Word
Powerpoint
Microsoft Excel
C++
Windows
Outlook
Html
Sql
Bing Zhu Photo 4

Bing Zhu

View page
Bing Zhu Photo 5

Bing Zhu

View page
Bing Zhu Photo 6

Bing Zhu

View page
Bing Zhu Photo 7

Bing Zhu

View page
Bing Zhu Photo 8

Bing Zhu

View page
Location:
United States

Publications

Isbn (Books And Publications)

Xin Wen Wu Bao Hu Fa Ji Shi Shi Tiao Li Wen Da

View page
Author

Bing Zhu

ISBN #

7801821947

Us Patents

Method For Diagnosing Neoplasia

View page
US Patent:
20030044861, Mar 6, 2003
Filed:
Apr 22, 2002
Appl. No.:
10/125823
Inventors:
Li Liu - North Wales PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Gary Piazza - Doylestown PA, US
Rifat Pamukcu - Spring House PA, US
International Classification:
G01N033/574
G01N001/30
G01N033/48
US Classification:
435/007230, 435/040500
Abstract:
This invention provides a method for diagnosing a patient with neoplasia.

Packaged Pharmaceuticals And Methods For Causing Compounds And Pharmaceutical Compositions To Be Used As Inhibitors Of Neoplastic Lesions

View page
US Patent:
20030175833, Sep 18, 2003
Filed:
Sep 20, 2002
Appl. No.:
10/251165
Inventors:
Li Liu - Ambler PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Rifat Pamukcu - Spring House PA, US
Gary Piazza - Doylestown PA, US
International Classification:
A61K031/00
G06F017/60
G01N033/574
US Classification:
435/007230, 514/001000, 705/003000
Abstract:
This invention provides pharmaceutical compositions containing compounds for the treatment of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibiton, growth inhibition and apoptosis induction, but prefereably not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.

Methods For Identifying Compounds For Inhibition Of Neoplastic Lesions, And Pharmacetical Compositions Containing Such Compounds

View page
US Patent:
20040009464, Jan 15, 2004
Filed:
Sep 24, 2002
Appl. No.:
10/253629
Inventors:
Li Liu - Ambler PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Rifat Pamukcu - Springhouse PA, US
Gary Piazza - Doylestown PA, US
International Classification:
C12Q001/00
A61K031/60
A61K031/415
US Classification:
435/004000, 514/165000, 514/406000
Abstract:
This invention provides pharmaceutical compositions containing compounds for the treatment of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibiton, growth inhibition and apoptosis induction, but prefereably not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.

Methods For Identifying Compounds For Inhibition Of Neoplastic Lesions, And Pharmaceutical Compositions Containing Such Compounds

View page
US Patent:
20050244914, Nov 3, 2005
Filed:
Jul 7, 2005
Appl. No.:
11/176073
Inventors:
Li Liu - Ambler PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Rifat Pamukcu - Springhouse PA, US
Gary Piazza - Doylestown PA, US
International Classification:
C12Q001/42
A61K031/519
US Classification:
435021000, 514262100
Abstract:
This invention provides pharmaceutical compositions containing compounds for the treatment of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibiton, growth inhibition and apoptosis induction, but prefereably not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.

Method Of Using A Novel Phosphodiesterase In Pharmaceutical Screeing To Identify Compounds For Treatment Of Neoplasia

View page
US Patent:
62007718, Mar 13, 2001
Filed:
Oct 15, 1998
Appl. No.:
9/173375
Inventors:
Li Liu - Northwales PA
Rifat Pamukcu - Spring House PA
W. Joseph Thompson - Doylestown PA
Gary A. Piazza - Doylestown PA
Han Li - Yardley PA
Bing Zhu - Mobile AL
Assignee:
Cell Pathways, Inc. - Hosham PA
International Classification:
C12Q 144
US Classification:
435 19
Abstract:
A method for identifying compounds useful for the treatment of neoplasia involves acertaining whether such compounds exhibit an ability to inhibit a PDE that is characterized by cGMP specificity, cooperative kinetic behavior and insensitivity to phosphorylation.
Bing Zhu from Mobile, AL, age ~57 Get Report